HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Permissions Request Permissions Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (10) Citing Articles via Google Scholar Google Scholar Articles by Bos, I. S. T. Articles by Zaagsma, J. Search for Related Content PubMed PubMed Citation Articles by Bos, I. S. T. Articles by Zaagsma, J.

Inhibition of allergen-induced airway remodelling by tiotropium and budesonide: a comparison

¹ Dept of Molecular Pharmacology, University of Groningen, Groningen, The Netherlands, ² Dept of Physiology, University of Manitoba, Winnipeg, MB, Canada, ³ Both authors contributed equally to this article.

CORRESPONDENCE: R. Gosens, Dept of Molecular Pharmacology, University of Groningen, Antonius Deusinglaan 1, 9713 AV Groningen, The Netherlands. Fax: 31 503636908. E-mail: r.gosens{at}rug.nl

Keywords: Airway remodelling, airway smooth muscle, anticholinergics, asthma, glucocorticosteroids, mucus hypersecretion

Received: January 13, 2007
Accepted May 18, 2007

Chronic inflammation in asthma and chronic obstructive pulmonary disease drives pathological structural remodelling of the airways. Using tiotropium bromide, acetylcholine was recently identified as playing a major regulatory role in airway smooth muscle remodelling in a guinea pig model of ongoing allergic asthma. The aim of the present study was to investigate other aspects of airway remodelling and to compare the effectiveness of tiotropium to the glucocorticosteroid budesonide.

Ovalbumin-sensitised guinea pigs were challenged for 12 weeks with aerosolised ovalbumin.

The ovalbumin induced airway smooth muscle thickening, hypercontractility of tracheal smooth muscle, increased pulmonary contractile protein (smooth-muscle myosin) abundance, mucous gland hypertrophy, an increase in mucin 5 subtypes A and C (MUC5AC)-positive goblet cell numbers and eosinophilia. It was reported previously that treatment with tiotropium inhibits airway smooth muscle thickening and contractile protein expression, and prevents tracheal hypercontractility. This study demonstrates that tiotropium also fully prevented allergen-induced mucous gland hypertrophy, and partially reduced the increase in MUC5AC-positive goblet cell numbers and eosinophil infiltration. Treatment with budesonide also prevented airway smooth muscle thickening, contractile protein expression, tracheal hypercontractility and mucous gland hypertrophy, and partially reduced MUC5AC-positive goblet cell numbers and eosinophilia.

This study demonstrates that tiotropium and budesonide are similarly effective in inhibiting several aspects of airway remodelling, providing further evidence that the beneficial effects of tiotropium bromide might exceed those of bronchodilation.

This article has been cited by other articles:

				S. Haag, S. Matthiesen, U. R. Juergens, and K. Racke Muscarinic receptors mediate stimulation of collagen synthesis in human lung fibroblasts Eur. Respir. J., September 1, 2008; 32(3): 555 - 562. [Abstract] [Full Text] [PDF]

				H. Meurs, R. Gosens, and J. Zaagsma Airway hyperresponsiveness in asthma: lessons from in vitro model systems and animal models Eur. Respir. J., August 1, 2008; 32(2): 487 - 502. [Abstract] [Full Text] [PDF]